open access
Aberrations in carbohydrate metabolism in patients with diagnosed acromegaly — observational study
, 1
Affiliations- Department of Endocrinology and Diabetology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland
open access
Abstract
Introduction: Acromegaly is characterized by excessive secretion of growth hormone (GH). The incidence rate of acromegaly is 40 to 70 persons per one million people. Carbohydrate disorders often accompany the above pathology. The aim of this study was to examine the influence of high levels of somatotropin on aberrations in glycaemia in patients with acromegaly, and then a 5-year observation.
Material and methods: The study group consisted of 86 patients (48 females and 38 males) with acromegaly diagnosed on the basis of clinical features, elevated insulin-like growth factor 1 (IGF-1) levels, and/or no inhibition of GH ≤ 1 ug/L secretion during 2 hours after an oral glucose load.
Results: In the study group type 2 diabetes mellitus (T2DM) was diagnosed in 21 patients (24.4%). There were also 14 cases (16.3%) of the diagnosis of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) combined. The mean age of participants with concomitant T2DM was 52.1 years, while the mean age of those without carbohydrate metabolism disturbances was 46.1 years. During a 5-year observation, we noticed an increase level of glycated haemoglobin (HbA1c) and new cases of pre-diabetes and T2DM.
Conclusion: In patients with acromegaly the incidence rate of T2DM is 3–4 times higher than in the rest of the population, and it increases with age, especially after the patient reaches 55 years old.
Abstract
Introduction: Acromegaly is characterized by excessive secretion of growth hormone (GH). The incidence rate of acromegaly is 40 to 70 persons per one million people. Carbohydrate disorders often accompany the above pathology. The aim of this study was to examine the influence of high levels of somatotropin on aberrations in glycaemia in patients with acromegaly, and then a 5-year observation.
Material and methods: The study group consisted of 86 patients (48 females and 38 males) with acromegaly diagnosed on the basis of clinical features, elevated insulin-like growth factor 1 (IGF-1) levels, and/or no inhibition of GH ≤ 1 ug/L secretion during 2 hours after an oral glucose load.
Results: In the study group type 2 diabetes mellitus (T2DM) was diagnosed in 21 patients (24.4%). There were also 14 cases (16.3%) of the diagnosis of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) combined. The mean age of participants with concomitant T2DM was 52.1 years, while the mean age of those without carbohydrate metabolism disturbances was 46.1 years. During a 5-year observation, we noticed an increase level of glycated haemoglobin (HbA1c) and new cases of pre-diabetes and T2DM.
Conclusion: In patients with acromegaly the incidence rate of T2DM is 3–4 times higher than in the rest of the population, and it increases with age, especially after the patient reaches 55 years old.
Keywords
acromegaly; T2DM; IGT; IGF-1
Supp./Additional Files (1)
About this articleTitle
Aberrations in carbohydrate metabolism in patients with diagnosed acromegaly — observational study
Journal
Issue
Article type
Brief communication
Pages
743-744
Published online
2022-07-18
Page views
4046
Article views/downloads
457
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2022;73(4):743-744.
Keywords
acromegaly
T2DM
IGT
IGF-1
Authors
Marcin Gierach
Roman Junik
References (10)- Barkan AL, Burman P, Clemmons DR, et al. Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant. J Clin Endocrinol Metab. 2005; 90(10): 5684–5691.
- Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest. 2009; 119(11): 3189–3202.
- Biering H, Knappe G, Gerl H, et al. [Prevalence of diabetes in acromegaly and Cushing syndrome]. Acta Med Austriaca. 2000; 27(1): 27–31.
- Colao A, Amato G, Pedroncelli AM, et al. Gender- and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest. 2002; 25(6): 532–538.
- Gierach M, Gierach J, Pujanek M, et al. Aberration in carbohydrate metabolism in patients with diagnosed acromegaly, hospitalized in the Endocrinology and Diabetology Department of Collegium Medicum University of Nicolaus Copernicus in Bydgoszcz in the years 2001-2009. Endokrynol Pol. 2010; 61(3): 260–263.
- Rogowicz-Frontczak A, Majchrzak A, Zozulińska-Ziółkiewicz D. Insulin resistance in endocrine disorders - treatment options. Endokrynol Pol. 2017; 68(3): 334–351.
- Dal J, List EO, Jørgensen JO, et al. Glucose and Fat Metabolism in Acromegaly: From Mice Models to Patient Care. Neuroendocrinology. 2016; 103(1): 96–105.
- Stelmachowska-Banaś M, Zdunowski P, Zgliczyński W. Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depends on the level of activity of the disease and the duration of the symptoms? Endokrynol Pol. 2009; 60(1): 20–24.
- Yun SJ, Lee JK, Park SoY, et al. Descriptive Epidemiology and Survival Analysis of Acromegaly in Korea. J Korean Med Sci. 2021; 36(23): e159.
- Puzianowska-Kuźnicka M, Januszkiewicz-Caulier J, Kurylowicz A, et al. Prevalence and socioeconomic predictors of diagnosed and undiagnosed diabetes in oldest-old and younger Caucasian seniors: results from the PolSenior study. Endokrynol Pol. 2021; 72(3): 249–255.
